ÂÜÀòÂÒÂ×

Carlos Campoy is an accomplished financial executive with extensive experience across the biopharmaceutical and healthcare sectors. Currently serving as a Board Member at Zymeworks Inc., Carlos holds the position of Audit Committee Chair and participates in the Nominating and Corporate Governance Committee. Prior roles include Chief Financial Officer at CytomX Therapeutics and Alder Biopharmaceuticals, where Carlos played a critical role in strategic execution and prepared Alder for a significant acquisition. Experience at Allergan involved leading financial operations for a $3 billion organization, while previous positions at Eli Lilly spanned various global leadership roles, contributing to significant revenue growth and operational restructuring. Carlos Campoy holds an MBA in Finance and Decision Information Systems from Indiana University and a Bachelor's degree from Faculdades FACCAT in Brazil.